VenatoRx Pharmaceuticals, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2010-06-04
- Employees
- 51
- Market Cap
- -
- Website
- http://www.venatorx.com
Safety and Pharmacokinetics of VNRX-5133 in the Epithelial Lining Fluid of Healthy Adult Subjects
- First Posted Date
- 2019-03-12
- Last Posted Date
- 2019-05-06
- Lead Sponsor
- Venatorx Pharmaceuticals, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT03870490
- Locations
- 🇺🇸
Hartford Hospital, Hartford, Connecticut, United States
Safety and Efficacy Study of Cefepime/VNRX-5133 in Patients With Complicated Urinary Tract Infections
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2019-02-15
- Last Posted Date
- 2024-05-29
- Lead Sponsor
- Venatorx Pharmaceuticals, Inc.
- Target Recruit Count
- 661
- Registration Number
- NCT03840148
- Locations
- 🇺🇸
Site 184001, La Mesa, California, United States
🇺🇸Site 184002, Chula Vista, California, United States
🇧🇬Site 110003, Ruse, Bulgaria
VNRX-5133 With VNRX-5022 in Subjects With Varying Degrees of Renal Impairment
- First Posted Date
- 2018-10-01
- Last Posted Date
- 2019-02-08
- Lead Sponsor
- Venatorx Pharmaceuticals, Inc.
- Target Recruit Count
- 33
- Registration Number
- NCT03690362
- Locations
- 🇺🇸
New Orleans Center for Clinical Research, Knoxville, Tennessee, United States
🇺🇸Orlando Cliniical Research Associates, Orlando, Florida, United States
VNRX-5133 Drug-Drug Interaction in Healthy Adult Volunteers
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-11-06
- Last Posted Date
- 2018-10-18
- Lead Sponsor
- Venatorx Pharmaceuticals, Inc.
- Target Recruit Count
- 42
- Registration Number
- NCT03332732
- Locations
- 🇺🇸
PRAHS, Lenexa, Kansas, United States
VNRX-5133 SAD/MAD Safety and PK in Healthy Adult Volunteers
- First Posted Date
- 2016-11-04
- Last Posted Date
- 2017-07-21
- Lead Sponsor
- Venatorx Pharmaceuticals, Inc.
- Target Recruit Count
- 84
- Registration Number
- NCT02955459
© Copyright 2024. All Rights Reserved by MedPath